Publikationen, an denen er mitarbeitet José Ángel Pérez Rivera (10)

2022

  1. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)

    European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301

2016

  1. Brain natriuretic peptide levels variation after left atrial appendage occlusion

    Catheterization and Cardiovascular Interventions, Vol. 87, Núm. 1, pp. E39-E43

2015

  1. Device embolisation after transcatheter paravalvular leak closure

    EuroIntervention

  2. Recurrent syncope after left atrial appendage occlusion

    Catheterization and Cardiovascular Interventions, Vol. 85, Núm. 2, pp. E58-E62

  3. The role of the TERC-63G>A and TERT-1327C>T telomerase polymorphisms in the study of men with acute coronary syndrome

    Minerva Cardioangiologica, Vol. 63, Núm. 6, pp. 467-474

2014

  1. Effect of telomere length on prognosis in men with acute coronary syndrome

    American Journal of Cardiology, Vol. 113, Núm. 3, pp. 418-421

  2. Significance of the learning curve in left atrial appendage occlusion with two different devices

    Catheterization and Cardiovascular Interventions, Vol. 83, Núm. 4, pp. 642-646

2013

  1. A 50-year old male smoker and obese with exertional dyspnea and muscle weakness of 2 months of evolution

    Medicine (Spain), Vol. 11, Núm. 35

2012

  1. Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome

    Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Núm. 11, pp. 1483-1493

  2. Prognostic value of telomere length in acute coronary syndrome

    Mechanisms of Ageing and Development, Vol. 133, Núm. 11-12, pp. 695-697